^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
GALEAS™ Tumor

Company:
Nonacus
Type:
Laboratory Developed Test
Related tests:
Evidence

News

6ms
Advanced Genomics APAC, CancerFree Biotech partner to combine NGS, drug response testing (Genomeweb)
"Advanced Genomics APAC and CancerFree Biotech on Friday announced a memorandum of understanding to create a partnership focused on creating personalized treatment plans for cancer patients using next-generation sequencing and in vitro drug testing."
Licensing / partnership
|
GALEAS™ Tumor
10ms
Nonacus launches test for comprehensive genomic profiling, integrated with bioinformatics and analysis software (Nonacus Press Release)
"Nonacus, has launched GALEASTM Tumor, a next generation sequencing (NGS) test that provides comprehensive genomic profiling of tumors, allowing clinicians to accurately diagnose cancers and tailor treatments."
Launch
|
GALEAS™ Tumor